Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Lymphoid 1Head & Neck 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Reperfusion Injury 1Lung Neoplasms 1End Stage Liver Disease 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Ketorolac × Thoracic × Clear all
NCT01932918 2015-07-23

Antinociceptive Modalities on Ischemia Reperfusion Injury

National Taiwan University Hospital

Completed
142 enrolled
Thoracic

Lung Neoplasms, Reperfusion Injury, End Stage Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡